Although in PD the involvement of TLR4 is less well compared to in AD and ALS, TLR4-mediated neuroinflammation can exacerbate the degeneration of dopaminergic neurons, suggesting that modulation of TLR4 activity might offer therapeutic potential (Conte et al., 2023). Here, TLR4 is linked to amyotrophic lateral sclerosis.